Clinical Trials Logo

Healthy Subjects clinical trials

View clinical trials related to Healthy Subjects.

Filter by:

NCT ID: NCT01478009 Completed - Healthy Subjects Clinical Trials

Efficacy of an Extract of Concentrated Korean Red Ginseng for Preventing Upper Respiratory Tract Infections

Start date: November 2010
Phase: Phase 2/Phase 3
Study type: Interventional

Upper respiratory tract infections are a major source of morbidity throughout the world. Extracts of Korean red ginseng have been found to have the potential to modulate both natural and acquired immune responses. The investigators sought to examine the efficacy of an extract of Korean red ginseng in preventing colds. Therefore, the efficacy and safety of Korean red ginseng will be investigated in healthy subjects during the influenza season.

NCT ID: NCT01476800 Completed - Healthy Subjects Clinical Trials

A Study to Assess Pharmacokinetic Interaction of Multiple Dose Ketoconazole on Single Dose YM178 Oral Controlled Absorption System (OCAS) in Healthy Adult Volunteers

Start date: July 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the pharmacokinetic interaction of multiple-dose ketoconazole on single-dose YM178 OCAS and the safety and tolerability of YM178 OCAS alone and in combination with ketoconazole in healthy adult volunteers.

NCT ID: NCT01476215 Completed - Healthy Subjects Clinical Trials

A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions

Start date: November 2009
Phase: Phase 1
Study type: Interventional

This proof of principle PK study will allow GSKCH to select the most favorable sustained release formulation among 3 prototypes to move to the next stage of drug development.

NCT ID: NCT01476189 Completed - Healthy Subjects Clinical Trials

A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol Formulations

Start date: November 2009
Phase: Phase 1
Study type: Interventional

A repeat dose pharmacokinetic study investigating two paracetamol formulations

NCT ID: NCT01458899 Completed - Healthy Subjects Clinical Trials

Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214

TC-5214
Start date: November 2011
Phase: Phase 1
Study type: Interventional

(Food versus no food) crossover study to measure the effects of food on pharmacokinetics of TC-5214 (S-Mecamylamine) in healthy Subjects.

NCT ID: NCT01443507 Completed - Healthy Subjects Clinical Trials

Effect of Exercise With Low Intensity and Longer Duration Versus High Intensity Interval Training

Start date: October 2011
Phase: Phase 2
Study type: Interventional

The purpose of the study is to compare exercise at 70% of maximal heart rate were total energy expenditure is twice compared to interval training at 90- 95% of maximal heart rate. Since 70% of maximal heart rate is well above the minimum threshold for improvements in maximal oxygen uptake it should be suited to investigate the effect of duration.

NCT ID: NCT01440478 Completed - Healthy Subjects Clinical Trials

The Effects of Urinary pH Changes on an Investigational Compound in Healthy Subjects

Start date: September 2011
Phase: Phase 1
Study type: Interventional

This study is designed to explore the effect of increased and decreased urinary pH on the single pharmacokinetic (PK) dose of LY2140023 and its active metabolite LY404039. All participants will receive the three treatments in a randomized order.

NCT ID: NCT01430065 Completed - Healthy Subjects Clinical Trials

Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Tacrolimus in Healthy Volunteers

Start date: June 2009
Phase: Phase 1
Study type: Interventional

This study characterizes the pharmacokinetic effects of ASP015K on Tacrolimus in healthy volunteers.

NCT ID: NCT01424332 Completed - Healthy Subjects Clinical Trials

To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects

Start date: December 2007
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to evaluate whether ASA and darexaban which have different effects on blood coagulation influence each other in their effects. Also it will be investigated whether the blood levels of either drug are influenced by the presence of the other drug. In addition, the safety and tolerability of each drug and the combination of the drugs will be investigated.

NCT ID: NCT01420094 Completed - Healthy Subjects Clinical Trials

Evaluate Onset of Action of a Fast Release Aspirin

TAROT compare
Start date: June 16, 2011
Phase: Phase 3
Study type: Interventional

To compare the safety and efficacy (onset, duration of relief and overall efficacy) of a single dose of a fast release formulation of aspirin 1000 mg compared to acetaminophen 1000 mg and placebo for relief of pain following extraction of impacted third molars.